Article
Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease.
Biochemistry - 28 Sept 2004
Clemente José C, Moose Rebecca E, Hemrajani Reena, Whitford Lisa R S, Govindasamy Lakshmanan, Reutzel Robbie, McKenna Robert, Agbandje-McKenna Mavis, Goodenow Maureen M, Dunn Ben M
Abstract excerpt
Protease inhibitor resistance still poses one of the greatest challenges in treating HIV. To better design inhibitors able to target resistant proteases, a deeper understanding is needed of the effects of accumulating mutations and the contributions of active- and nonactive-site mutations to the resistance. We have engineered a series of variants containing the nonactive-site mutations M46I and I54V and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
